JPRN-UMIN000007841已完成未知
Phase I study of immuno-Cell therapy for advanced and recurrent esophageal squamous cell carcinoma - Phase I study of immuno-Cell therapy for advanced and recuerent esophageal squamous cell carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.patient who has severe complication 2.patient who has bleeding tendency 3.patient who has active infectious disease 4.concomitant treatment with steroids 5.HBs antigen, HCV antibody, HIV antibody or HTLV-1 antibody is positive 6.patient who has activated autoimmune disease 7.patient who was judged to be unsuitable for this clinical trial
研究者
相似试验
已完成
1 期
A phase I clinical study of immune cell therapy with MAGE-A4- or Survivin-specific Th1 cells for patients with refractory virulent tumorsRefractory cancer patients (MAGE-A4- or Survivin-expressing, non origin-limited) or the patients who refuse standard cancer therapyJPRN-UMIN000004828Department of General Surgery, Hokkaido University Graduated School of Medicine18
已完成
不适用
Clinical study of adjuvant immuno-cell therapy for pancreatic cancer curatively resectable.Pancreatic cancerJPRN-C000000414Yokohama City University Hospital10
未知
1 期
Phase I/II study of adoptive immunotherapy using cytotoxic T cells specific for minor histocompatibility antigen restricted to hematopoietic cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantatio1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CMJPRN-C000000162Aichi Cancer Center30
已完成
2 期
Prostate Cancer: An internal, solid-malignancy model for vaccine therapyHormone refractory prostate cancerCancer - ProstateACTRN12605000589684Queensland Institute of Medical Research (QIMR)30
已完成
不适用
Phase I/IIa Study of Adoptive Immunotherapy Comprising 2-Methyl-3-Butenyl-1-Pyrophosphate-Stimulated Gamma Delta T Cells in Patients With PSA biochemical failure after radical prostatectomy.JPRN-UMIN000006617Tokyo Women's Medical University10